 |
Throat Swab Rapid Diagnostic Test Kit , Nucleic Acid Diagnostic Throat Test kits
Product Details:
| Place of Origin: | Beijing |
| Certification: | CE; ISO |
Payment & Shipping Terms:
| Minimum Order Quantity: | 10-100pcs |
|---|---|
| Price: | USD1.8-3.5/pc |
| Packaging Details: | 25pcs per case |
| Delivery Time: | 3-5working days |
| Supply Ability: | 1million per week |
|
Detail Information |
|||
| Sample Type: | Nasal/Throat Swab | Overall Agreement: | 97.5% |
|---|---|---|---|
| Certificate: | CE | Sensitivity: | 95.52% |
| Clinical Sensitivity Is 91.08%: | 91.08% | Detection Substance: | Nucleic Acid |
| High Light: | Nasal Swab Rapid Diagnostic Test Kit,Throat Swab Rapid Diagnostic Test Kit,Nucleic Acid Diagnostic Throat Test kits |
||
Product Description
Throat Swab Rapid Diagnostic Test Kit , Nucleic Acid Diagnostic Throat Test kits
CE approved Rapid Diagnostic Test Kit Antigen Fast Diagnostic Throat Test kits Nasal Swab Fast Test
Overall Clinical Performance of Antigen Test Kit
A total of above 157 positive samples and 260 negative samples were detected to evaluate the clinical performance of the COVID-19 Antigen Rapid Test Kit. The Result is below:
| Sansure Covid-19 RT-PCR Assay | ||||
| Positive | Negative | Total | ||
| Kewei COVID-19 Antigen Rapid Assay | Positive | 143 | 0 | 143 |
| Negative | 14 | 260 | 274 | |
| Total | 157 | 260 | 417 | |
The assay demonstrated acceptable total clinical sensitivity is 91.08% (95% CI: 85.59%-94.61%) when compared to a molecular device produced by Sansure Inc. The assay demonstrated excellent clinical specificity 100% (95% CI: 98.54%-100%). Overall Agreement was 96.64% (94.44%-97.99%).
Limit of Detection(LoD)
Limit of detection (LoD) was determined by evaluating different concentrations of heat inactivated SARS-CoV-2 virus. LoD of the SARS-CoV-2 antigen rapid kit was confirmed as 38.5 TCID50/ml.
